Mylan N.V. recently released a statement in response to a Financial Times article entitled “HIV/Aids drug for developing world face threat of disruption.” Read More »

Concert Pharmaceuticals Inc. has received a second request from the Federal Trade Commission for the acquisition of CTP-656, as well as other options for cystic fibrosis treatment, produced by Vertex Pharmaceuticals Inc. Read More »

CVS Pharmacy is launching a new campaign during the month of May, by the name of Long Live Skin. Read More »

Amgen announced May 2 that they had signed an outcome-based refund contract with Harvard Pilgrim for Amgen's Repatha. Read More »

BiologicTx marked a year of successful transplants using its paired donation software, BiologicTx MatchGrid. Read More »

Pharmacy benefit managers are changing the way that prescriptions are filled, reducing the costs for patients and increasing the value for all involved. Read More »

Biologics Inc., a McKesson Specialty Health company, has been selected by Takeda Pharmaceutical Co. to be a “specialty pharmacy provider” for ALUNBRIG, a Takeda-manufactured drug for anaplastic lymphoma kinase positive metastatic non-small cell lung cancer. Read More »

fred’s Pharmacy was pleased to report they screened over 98,000 people for heart disease and detection during their Heart Disease Awareness and Colorectal Cancer Campaigns, and made a huge donation of $38,244 to the American Heart Association this month. Read More »

Express Scripts has acquired myMatrixx to combine its integrated pharmacy benefit management services with myMatrixx's workers' compensation pharmacy benefits experience. Read More »

CVS Health will nationally sponsor the American Heart Association’s Go Red For Women and pledge to raise $10 million over the next three years in support of life-saving cardiovascular research and education. Read More »

Advanced Pharma Inc., which does business as Avella of Houston, is voluntarily recalling unexpired sterile injectable products labeled "latex free" that were produced at the company’s Houston location between Sep. 1, 2016 and Feb. 16, 2017. Read More »

Valeant Pharmaceuticals Inc. and EyeGate Pharmaceuticals have entered an exclusive, global licensing agreement. Read More »

Allegra drug developer Sanofi supports Bike to Work Day, a day where Americans are urged to ride bicycles to work instead of driving. Read More »

GSK has made a $139 million investment in a biopharmaceutical manufacturing site in Rockville, Maryland. Read More »

The American Society of Health-System Pharmacists has awarded 11 pharmacy students with both recognition and a cash reward for their excellence in their education, both on campus and pharmacy practice. Read More »

CVs Health has earned #50 in the ranking for DiversityInc's 2017 Top 50 Companies for Diversity. This is the first time that CVS has been on the list, though it was #25 on the Noteworthy listing in the past. Read More »

Imprimis Pharmaceuticals Inc., and SightLife Surgical have signed a sales and marketing agreement in which SightLife will be offering Imprimis' autologous eye drops, Serum Tears, which have been specially formulated for patients suffering from chronic dry eye who require more than traditional treatment. Read More »

PharmaCyte Biotech, Inc., announced that they would be winning the 2017 Buzz of BIO "Pipelines of Promise" award prior to the 2017 BIO International Convention. Read More »

DelMar Pharmaceuticals Inc., a company fighting for cancer patients and therapies, decreased its public stock aggregate share from 2.77 million to 2.08 million this month. Read More »

Amgen and Novartis are working together to fight against migraines with erenumab, an expanded commercial collaboration building on a global neuroscience collaboration in Alzheimer's disease and migraine established in 2015. Read More »